PRIMALung (EORTC-1901): PRophylactic cerebral irradiation (PCI) or active brain MAgnetic resonance imaging (MRI) surveillance in small-cell lung cancer (SCLC) patients
Levy, A. Berghmans, T. Koller, M. Fournier, B. Mauer, M. Andratschke, N.
Levy, A.
Berghmans, T.
Koller, M.
Fournier, B.
Mauer, M.
Andratschke, N.
Citations
Altmetric:
Abstract
The PRIMALung EORTC-1901 trial investigates brain MRI ± PCI in all-stages of SCLC, aiming for non-inferior survival, improve cognition in the era of immunotherapy. @finn_corinne.
Description
Date
2024
Publisher
Collections
Keywords
Type
Article
Citation
Levy A, Berghmans T, Koller M, Fournier B, Mauer M, Andratschke N, et al. PRIMALung (EORTC-1901): PRophylactic cerebral irradiation (PCI) or active brain MAgnetic resonance imaging (MRI) surveillance in small-cell lung cancer (SCLC) patients. Lung cancer (Amsterdam, Netherlands). 2024 Dec;198:107993. PubMed PMID: 39541773. Epub 2024/11/15. eng.